Be skeptical of specific numbers (e.g., a particular half-life in hours, or a specific oral bioavailability percentage) circulating on commercial or community sites these could not be located in peer-reviewed literature and directly conflict with the peer-reviewed consensus that no human trials of this compound have been conducted
doi: 10.1186/s13075-019-2038-0
and is not FDA-approved for any human application
Use daily for best results
Nasseri takes a customized approach to treatment, ensuring each client receives the right dosage to meet their unique health needs
Compatibility The vast majority of research peptides in this catalog including GLP-1 agonists, GHRH analogues, GHRPs, BPC-157, TB-500, Semax, Selank, and many others reconstitute cleanly and stably in bacteriostatic water without precipitation, aggregation, or activity loss